OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors
Toby N. Trahair, Andrew J. Gifford, Ashleigh M. Fordham, et al.
JCO Precision Oncology (2019), Iss. 3, pp. 1-11
Open Access | Times Cited: 46
Toby N. Trahair, Andrew J. Gifford, Ashleigh M. Fordham, et al.
JCO Precision Oncology (2019), Iss. 3, pp. 1-11
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)
Michela Casanova, Bernadette Brennan, Rita Alaggio, et al.
European Journal of Cancer (2020) Vol. 127, pp. 123-129
Closed Access | Times Cited: 108
Michela Casanova, Bernadette Brennan, Rita Alaggio, et al.
European Journal of Cancer (2020) Vol. 127, pp. 123-129
Closed Access | Times Cited: 108
Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges
Priya Mahajan, Michela Casanova, Andrea Ferrari, et al.
Current Problems in Cancer (2021) Vol. 45, Iss. 4, pp. 100768-100768
Closed Access | Times Cited: 61
Priya Mahajan, Michela Casanova, Andrea Ferrari, et al.
Current Problems in Cancer (2021) Vol. 45, Iss. 4, pp. 100768-100768
Closed Access | Times Cited: 61
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment
Paulina Chmiel, ALEKSANDRA SłOWIKOWSKA, Łukasz Banaszek, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 7, pp. 1141-1162
Open Access | Times Cited: 13
Paulina Chmiel, ALEKSANDRA SłOWIKOWSKA, Łukasz Banaszek, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 7, pp. 1141-1162
Open Access | Times Cited: 13
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, et al.
European Journal of Cancer (2021) Vol. 157, pp. 198-213
Open Access | Times Cited: 45
Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, et al.
European Journal of Cancer (2021) Vol. 157, pp. 198-213
Open Access | Times Cited: 45
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor
Qian Wang, Huan‐Wu Chen, Ren‐Chin Wu, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 12, pp. 1683-1702
Open Access | Times Cited: 18
Qian Wang, Huan‐Wu Chen, Ren‐Chin Wu, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 12, pp. 1683-1702
Open Access | Times Cited: 18
Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring PRRC2B-ALK Rearrangement: A Case Report
Zhan Wang, Yan Geng, Lingyan Yuan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Zhan Wang, Yan Geng, Lingyan Yuan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer
Allison L. Hunt, Aratara Nutcharoen, Jamie Randall, et al.
The Oncologist (2023) Vol. 28, Iss. 8, pp. 730-736
Open Access | Times Cited: 15
Allison L. Hunt, Aratara Nutcharoen, Jamie Randall, et al.
The Oncologist (2023) Vol. 28, Iss. 8, pp. 730-736
Open Access | Times Cited: 15
TREATMENT AND OUTCOMES IN PEDIATRIC INFLAMMATORY MYOFIBROBLASTIC TUMORS – A SYSTEMATIC REVIEW OF PUBLISHED STUDIES
Arimatias Raitio, Paul D. Losty
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 7, pp. 108388-108388
Closed Access | Times Cited: 6
Arimatias Raitio, Paul D. Losty
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 7, pp. 108388-108388
Closed Access | Times Cited: 6
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma
Ashleigh M. Fordham, Jinhan Xie, Andrew J. Gifford, et al.
British Journal of Cancer (2020) Vol. 123, Iss. 7, pp. 1101-1113
Open Access | Times Cited: 29
Ashleigh M. Fordham, Jinhan Xie, Andrew J. Gifford, et al.
British Journal of Cancer (2020) Vol. 123, Iss. 7, pp. 1101-1113
Open Access | Times Cited: 29
Inflammatory myofibroblastic tumors in children: clinical characteristics and treatment outcomes with a focus on targeted therapies
Ülkü Miray Yıldırım, Rejin Kebudi, Bülent Zülfikar, et al.
The Turkish Journal of Pediatrics (2025) Vol. 67, Iss. 1, pp. 51-60
Open Access
Ülkü Miray Yıldırım, Rejin Kebudi, Bülent Zülfikar, et al.
The Turkish Journal of Pediatrics (2025) Vol. 67, Iss. 1, pp. 51-60
Open Access
Inflammatory myofibroblastic tumor in the liver after bone marrow transplantation: case report and literature review
Yang Shuhui, Tang Yongsheng, Yuan Zenan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Yang Shuhui, Tang Yongsheng, Yuan Zenan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Clinical diagnosis and treatment of abdominal inflammatory myofibroblastic tumors
Qiang Zhang, Zhiwei Zhang, Jing Fan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Qiang Zhang, Zhiwei Zhang, Jing Fan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Therapeutic strategy and prognostic analysis of inflammatory myofibroblastic tumor in the head and neck: a retrospective study
Feng Liu, Yanchao Qin, Zhiwei Zhang, et al.
PeerJ (2025) Vol. 13, pp. e19315-e19315
Open Access
Feng Liu, Yanchao Qin, Zhiwei Zhang, et al.
PeerJ (2025) Vol. 13, pp. e19315-e19315
Open Access
Inflammatory Myofibroblastic Tumour of the Bladder in a Young Male: A Rare Case Report
Mohamed Hashim, Suhaila Abdullah, Chin Yiun Lee, et al.
Cureus (2025)
Open Access
Mohamed Hashim, Suhaila Abdullah, Chin Yiun Lee, et al.
Cureus (2025)
Open Access
Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report
Danila Comandini, Fabio Catalano, Massimiliano Grassi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Danila Comandini, Fabio Catalano, Massimiliano Grassi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents
Aurore Pire, Daniel Orbach, Louise Galmiche, et al.
Pediatric Blood & Cancer (2021) Vol. 69, Iss. 5
Closed Access | Times Cited: 21
Aurore Pire, Daniel Orbach, Louise Galmiche, et al.
Pediatric Blood & Cancer (2021) Vol. 69, Iss. 5
Closed Access | Times Cited: 21
Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
Wen-I Chang, Claire Lin, Nicholas R. Liguori, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 16
Wen-I Chang, Claire Lin, Nicholas R. Liguori, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 16
Inflammatory myofibroblastic tumor: Amulti‐institutional study from the Pediatric Surgical Oncology Research Collaborative
Barrie S. Rich, Joanna Fishbein, Timothy B. Lautz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 7, pp. 1059-1067
Closed Access | Times Cited: 16
Barrie S. Rich, Joanna Fishbein, Timothy B. Lautz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 7, pp. 1059-1067
Closed Access | Times Cited: 16
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
Mengmeng Li, Ruyue Xing, Jiuyan Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Mengmeng Li, Ruyue Xing, Jiuyan Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Clinical characteristics and prognosis of pulmonary inflammatory myofibroblastic tumor: An over 10‐year retrospective analysis
Na Zhang, Qi Zeng, Chenghao Chen, et al.
Pediatric Investigation (2020) Vol. 4, Iss. 3, pp. 192-197
Open Access | Times Cited: 20
Na Zhang, Qi Zeng, Chenghao Chen, et al.
Pediatric Investigation (2020) Vol. 4, Iss. 3, pp. 192-197
Open Access | Times Cited: 20
Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib
Sumaira Khalil, Tariq Ghafoor, Amna Kaneez Fatima Raja
Case Reports in Oncological Medicine (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 18
Sumaira Khalil, Tariq Ghafoor, Amna Kaneez Fatima Raja
Case Reports in Oncological Medicine (2020) Vol. 2020, pp. 1-6
Open Access | Times Cited: 18
Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group
Beth Fisher, Ashley Meyer, Anastasia Brown, et al.
Journal of Pediatric Hematology/Oncology Nursing (2024) Vol. 41, Iss. 2, pp. 114-128
Closed Access | Times Cited: 2
Beth Fisher, Ashley Meyer, Anastasia Brown, et al.
Journal of Pediatric Hematology/Oncology Nursing (2024) Vol. 41, Iss. 2, pp. 114-128
Closed Access | Times Cited: 2
Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
Weidong Dou, Yu Guan, Tao Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Weidong Dou, Yu Guan, Tao Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid Tumors
Andrew J. Bellantoni, Lars M. Wagner
Cancers (2021) Vol. 13, Iss. 14, pp. 3531-3531
Open Access | Times Cited: 10
Andrew J. Bellantoni, Lars M. Wagner
Cancers (2021) Vol. 13, Iss. 14, pp. 3531-3531
Open Access | Times Cited: 10
Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs
Rachel V. Brady, Robert B. Rebhun, Katherine A. Skorupski, et al.
Journal of Veterinary Diagnostic Investigation (2022) Vol. 34, Iss. 3, pp. 465-473
Open Access | Times Cited: 7
Rachel V. Brady, Robert B. Rebhun, Katherine A. Skorupski, et al.
Journal of Veterinary Diagnostic Investigation (2022) Vol. 34, Iss. 3, pp. 465-473
Open Access | Times Cited: 7
